Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2017
Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemiaLewis B Silverman
Pediatric Blood & Cancer|October 19, 2007
Acute lymphoblastic leukemia in infancyLewis B Silverman
Hematology. American Society of Hematology. Education Program|February 20, 2015
Balancing cure and long-term risks in acute lymphoblastic leukemiaLewis B Silverman
Current Opinion in Pediatrics|February 27, 2009
Childhood acute lymphoblastic leukemia: update on prognostic factorsLynda M Vrooman, Lewis B Silverman
Current Opinion in Hematology|June 12, 2003
Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatmentLewis B Silverman, Stephen E Sallan
Current Hematologic Malignancy Reports|August 10, 2016
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical AdvancesLynda M Vrooman, Lewis B Silverman
Current Hematologic Malignancy Reports|April 29, 2010
Acute lymphoblastic leukemia in adolescents and young adultsElly V Barry, Lewis B Silverman
Blood|July 30, 2011
Childhood T-all: it's time to move onJames A Whitlock, Lewis B Silverman
Hematology. American Society of Hematology. Education Program|February 20, 2015
CNS prophylaxis in pediatric acute lymphoblastic leukemiaEdward Allan R Sison, Lewis B Silverman
JAMA Oncology|June 10, 2021
Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children: Essential Tools in the Era of the Research to Accelerate Cures and Equity ActAndrea Arfè, Lewis B Silverman, Florence Bourgeois
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Hematology. American Society of Hematology. Education Program|December 10, 2017
Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemiaLewis B Silverman
Pediatric Blood & Cancer|October 19, 2007
Acute lymphoblastic leukemia in infancyLewis B Silverman
Hematology. American Society of Hematology. Education Program|February 20, 2015
Balancing cure and long-term risks in acute lymphoblastic leukemiaLewis B Silverman
Current Opinion in Pediatrics|February 27, 2009
Childhood acute lymphoblastic leukemia: update on prognostic factorsLynda M Vrooman, Lewis B Silverman
Current Opinion in Hematology|June 12, 2003
Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatmentLewis B Silverman, Stephen E Sallan
Current Hematologic Malignancy Reports|August 10, 2016
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical AdvancesLynda M Vrooman, Lewis B Silverman
Current Hematologic Malignancy Reports|April 29, 2010
Acute lymphoblastic leukemia in adolescents and young adultsElly V Barry, Lewis B Silverman
Blood|July 30, 2011
Childhood T-all: it's time to move onJames A Whitlock, Lewis B Silverman
Hematology. American Society of Hematology. Education Program|February 20, 2015
CNS prophylaxis in pediatric acute lymphoblastic leukemiaEdward Allan R Sison, Lewis B Silverman
JAMA Oncology|June 10, 2021
Master Protocols and Adaptive Trial Designs to Develop Tumor-Agnostic Drugs for Children: Essential Tools in the Era of the Research to Accelerate Cures and Equity ActAndrea Arfè, Lewis B Silverman, Florence Bourgeois
Pageof 19